RELIGRAST 300 MG

About

Filgrastim is a recombinant human granulocyte colony-stimulating factor (G-CSF), a cytokine that plays a pivotal role in the regulation of neutrophil production and release from the bone marrow. Its primary therapeutic application is to mitigate the incidence and duration of neutropenia, a condition characterized by abnormally low levels of neutrophils, which are crucial infection-fighting white blood cells. This medication is commonly administered to patients undergoing myelosuppressive chemotherapy for non-myeloid malignancies, following bone marrow transplantation, or in individuals diagnosed with severe chronic neutropenia. By stimulating the proliferation, differentiation, and activation of neutrophil precursors, Filgrastim effectively increases circulating neutrophil counts, thereby significantly reducing the risk of severe infections and febrile neutropenia, which can be life-threatening complications of various medical treatments and conditions.

Uses

• Chemotherapy-induced neutropenia
• Bone marrow transplantation
• Severe chronic neutropenia
• Mobilization of peripheral blood progenitor cells

Directions For Use

Administer subcutaneously or intravenously as directed by a healthcare provider.

Benefits

• Reduces incidence of febrile neutropenia
• Shortens duration of neutropenia
• Decreases risk of infection
• Allows for on-schedule chemotherapy
• Enhances immune response
• Increases neutrophil count

Side Effects

• Bone pain
• Myalgia
• Headache
• Fatigue
• Nausea
• Vomiting
• Diarrhea
• Splenomegaly (rare)
• Allergic reactions
• Injection site reactions
• Thrombocytopenia
• Leukocytosis

Safety Measures

• Alcohol - No specific interaction, but alcohol can affect overall health during chemotherapy.
• Pregnancy - Use only if potential benefit justifies potential risk to fetus. Consult a doctor.
• Breastfeeding - Unknown if excreted in breast milk; use with caution. Consult a doctor.
• Liver - No specific dose adjustment needed, but monitor overall health.
• Kidney - No specific dose adjustment needed, but monitor overall health.
• Lung - Rare cases of acute respiratory distress syndrome (ARDS) reported.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.